Jennifer Alissa Loyer-Drew

This inventor holds 12 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignee: Gilead Sciences, Inc.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Alissa Loyer-Drew. Retrieved from https://idiyas.com/inventor/jennifer-alissa-loyer-drew

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 91.7

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 14.9

ph-index = 3

Forward Citations = 17(Granted Patents)

Company Filing History:

12 out of 946

Gilead Sciences, Inc.

patents

Years Active: 2013-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12258346 - Substituted 6-azabenzimidazole compounds (2025-03-25),

2. 12240862 - Inhibitors of peptidylarginine deiminases (2025-03-04),

3. 11976083 - Inhibitors of peptidylarginine deiminases (2024-05-07),

4. 11925631 - Substituted 6-azabenzimidazole compounds (2024-03-12),

5. 11897878 - Substituted 6-azabenzimidazole compounds (2024-02-13),

6. 11878965 - Inhibitors of peptidylarginine deiminases (2024-01-23),

7. 11203591 - Substituted 6-azabenzimidazole compounds (2021-12-21),

8. 11071730 - Substituted 6-azabenzimidazole compounds (2021-07-27),

9. 11021467 - Phosphatidylinositol 3-kinase inhibitors (2021-06-01),

10. 10092563 - Phosphatidylinositol 3-kinase inhibitors (2018-10-09),

11. 9951065 - Benzimidazole and imadazopyridine carboximidamide compounds (2018-04-24),

12. 8394829 - Bi-functional quinoline analogs (2013-03-12),

Certainly! Here is an article about the inspiring inventor Jennifer Alissa Loyer-Drew:

Title: Jennifer Alissa Loyer-Drew: Pioneering Innovation for a Better Tomorrow

Introduction:

Jennifer Alissa Loyer-Drew, a remarkable inventor based in Seattle, Washington, is a beacon of innovation in the world of inventors. With a deep passion for creating solutions that drive positive change, she has dedicated her career to developing cutting-edge technologies that have the potential to shape the future.

Latest Patents:

Jennifer's latest patents include Substituted 6-azabenzimidazole compounds. These compounds, along with the pharmaceutical compositions comprising them, offer promising methods for treating or preventing diseases modifiable by hematopoietic progenitor kinase 1 (HPK1) inhibitors. Such conditions include HBV, HIV, cancer, and hyper-proliferative diseases.

Career Highlights:

Currently working at Gilead Sciences, Inc., Jennifer has amassed an impressive portfolio of 9 patents. Her innovative spirit and commitment to advancing medical research have positioned her as a key player in the field of biotechnology.

Collaborations:

In her groundbreaking work, Jennifer collaborates closely with esteemed colleagues such as Joshua J Van Veldhuizen and Gary B Phillips. Together, they synergize their expertise to push the boundaries of scientific discovery and bring novel solutions to fruition.

Conclusion:

Jennifer Alissa Loyer-Drew's unwavering dedication to innovation and her unwavering commitment to creating a better future through her inventions exemplify the true essence of an inspiring inventor. Her contributions not only demonstrate her technical prowess but also underscore her vision for a world where technology serves humanity's highest good.

I hope you find this article insightful and inspiring! If you need more information or have any other requests, feel free to let me know.

Profile summary based on public USPTO records.